AnaptysBio Inc buy JPMorgan Chase & Co.
Start price
19.12.24
/
50%
€14.50
Target price
19.12.25
€34.70
Performance (%)
182.76%
End price
20.12.25
€41.00
Summary
This prediction ended on 20.12.25 with a price of €41.00. The BUY prediction by JPMorgan_Chase___Co_ for AnaptysBio Inc saw massive gains of 182.76%. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| AnaptysBio Inc | -6.129% | -6.129% | 108.246% |
| iShares Core DAX® | 0.855% | 0.389% | 2.533% |
| iShares Nasdaq 100 | -0.989% | -4.400% | 25.154% |
| iShares Nikkei 225® | -1.781% | -11.216% | 44.398% |
| iShares S&P 500 | 0.057% | 0.778% | 20.953% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at JPMorgan Chase & Co. from $66.00 to $36.00. They now have an "overweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat
In the thread Trading AnaptysBio Inc
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten